These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 12758242

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. High dose-rate brachytherapy for elderly patients with uterine cervical cancer.
    Chen SW, Liang JA, Yang SN, Lin FJ.
    Jpn J Clin Oncol; 2003 May; 33(5):221-8. PubMed ID: 12865465
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
    Zhang M, Xu HD, Pan SD, Lin S, Yue JH, Liu JR.
    Int J Radiat Oncol Biol Phys; 2012 Jul 01; 83(3):966-71. PubMed ID: 22138462
    [Abstract] [Full Text] [Related]

  • 6. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R, Knocke TH, Fellner C, Baldass M, Reinthaller A, Kucera H.
    Cancer Radiother; 2000 Jul 01; 4(2):159-72. PubMed ID: 10812362
    [Abstract] [Full Text] [Related]

  • 7. High-dose-rate brachytherapy at 14 Gy per hour to point A: preliminary results of a prospectively designed schedule for cancer of the cervix based on the linear-quadratic model.
    Leborgne F, Leborgne JH, Zubizarreta E, Fowler JF, Maisonneuve J, Ferrari D, Curochquin R.
    Int J Gynecol Cancer; 2001 Jul 01; 11(6):445-53. PubMed ID: 11906547
    [Abstract] [Full Text] [Related]

  • 8. Prognostic factors in definitive radiotherapy of uterine cervical cancer.
    Yalman D, Aras AB, Ozkök S, Duransoy A, Celik OK, Ozsaran Z, Haydaroğlu A.
    Eur J Gynaecol Oncol; 2003 Jul 01; 24(3-4):309-14. PubMed ID: 12807246
    [Abstract] [Full Text] [Related]

  • 9. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix.
    Perez CA, Grigsby PW, Chao KS, Mutch DG, Lockett MA.
    Int J Radiat Oncol Biol Phys; 1998 May 01; 41(2):307-17. PubMed ID: 9607346
    [Abstract] [Full Text] [Related]

  • 10. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.
    Kim WC, Kim GE, Suh CO, Loh JJ.
    Jpn J Clin Oncol; 2001 Sep 01; 31(9):432-7. PubMed ID: 11689597
    [Abstract] [Full Text] [Related]

  • 11. High-dose-rate afterloading brachytherapy in carcinoma of the cervix: an experience of 1992 patients.
    Lorvidhaya V, Tonusin A, Changwiwit W, Chitapanarux I, Srisomboon J, Wanwilairat S, Chawapun N, Sukthomya V.
    Int J Radiat Oncol Biol Phys; 2000 Mar 15; 46(5):1185-91. PubMed ID: 10725630
    [Abstract] [Full Text] [Related]

  • 12. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
    Lee SW, Suh CO, Chung EJ, Kim GE.
    Int J Radiat Oncol Biol Phys; 2002 Apr 01; 52(5):1338-44. PubMed ID: 11955747
    [Abstract] [Full Text] [Related]

  • 13. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.
    Atlan D, Touboul E, Deniaud-Alexandre E, Lefranc JP, Antoine JM, Jannet D, Lhuillier P, Uzan M, Huart J, Genestie C, Antoine M, Jamali M, Ganansia V, Milliez J, Uzan S, Blondon J.
    Int J Radiat Oncol Biol Phys; 2002 Nov 01; 54(3):780-93. PubMed ID: 12377330
    [Abstract] [Full Text] [Related]

  • 14. High dose rate brachytherapy for carcinoma of the uterine cervix: comparison of two different fractionation regimens.
    Le Pechoux C, Akine Y, Sumi M, Tokuuye K, Ikeda H, Yajima M, Yamada T, Tanemura K, Tsunematsu R, Ohmi K.
    Int J Radiat Oncol Biol Phys; 1995 Feb 15; 31(4):735-41. PubMed ID: 7860384
    [Abstract] [Full Text] [Related]

  • 15. Transperineal low-dose rate iridium-192 interstitial brachytherapy in cervical carcinoma stage IIB.
    Budrukkar AN, Shrivastava SK, Jalali R, Agarwal JP, Deshpande DD, Nehru RM, Dinshaw KA.
    Strahlenther Onkol; 2001 Oct 15; 177(10):517-24. PubMed ID: 11680016
    [Abstract] [Full Text] [Related]

  • 16. High-dose-rate intracavitary brachytherapy (HDR-IC) in treatment of cervical carcinoma: 5-year results and implication of increased low-grade rectal complication on initiation of an HDR-IC fractionation scheme.
    Wang CJ, Leung SW, Chen HC, Sun LM, Fang FM, Changchien CC, Huang EY, Wu JM, Chen CC.
    Int J Radiat Oncol Biol Phys; 1997 May 01; 38(2):391-8. PubMed ID: 9226328
    [Abstract] [Full Text] [Related]

  • 17. An audit of the treatment of carcinoma of the uterine cervix using external beam radiotherapy and a single line source brachytherapy technique.
    Tan LT, Jones B, Gee A, Kingston RE.
    Br J Radiol; 1997 Dec 01; 70(840):1259-69. PubMed ID: 9505845
    [Abstract] [Full Text] [Related]

  • 18. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
    Petereit DG, Sarkaria JN, Potter DM, Schink JC.
    Int J Radiat Oncol Biol Phys; 1999 Dec 01; 45(5):1267-74. PubMed ID: 10613322
    [Abstract] [Full Text] [Related]

  • 19. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD, Rai B, Mallick I, Sharma SC.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):125-30. PubMed ID: 15850912
    [Abstract] [Full Text] [Related]

  • 20. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R, Nishimoto IN, Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Salvajoli JV.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1108-16. PubMed ID: 15990016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.